1. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models
   Erenius Toppo et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Aquaglyceroporins: Drug Targets for Metabolic Diseases?
   Giuseppe Calamita et al, 2018, Frontiers in Physiology CrossRef
3. Integrated multiomics analysis reveals changes in liver physiological function in Aqp9 gene knockout mice
   Quancheng Cheng et al, 2023, International Journal of Biological Macromolecules CrossRef
4. Aquaglyceroporin Modulators as Emergent Pharmacological Molecules for Human Diseases
   Catarina Pimpão et al, 2022, Frontiers in Molecular Biosciences CrossRef
5. Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease
   Juyi Li et al, 2023, International Journal of General Medicine CrossRef
6. Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis
   S. Sylvester Darvin et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. Involvement of aquaglyceroporins in energy metabolism in health and disease
   Giuseppe Calamita et al, 2021, Biochimie CrossRef
8. Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats
   Leire Méndez-Giménez et al, 2015, Obesity Surgery CrossRef
9. Effects of Rhizoma Alismatis extract on biochemical indices and adipose gene expression in oleic acid-induced hepatocyte injury in Jian carp (Cyprinus carpio var. Jian)
   Jinliang Du et al, 2018, Fish Physiology and Biochemistry CrossRef
10. The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
    Inês V. da Silva et al, 2022, Biomolecules CrossRef
11. Mammalian aquaglyceroporin function in metabolism
    Umberto Laforenza et al, 2016, Biochimica et Biophysica Acta (BBA) - Biomembranes CrossRef
12. Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis
    Song Wang et al, 2016, BioMetals CrossRef
13. Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins
    Inês Vieira da Silva et al, 2018, Cellular and Molecular Life Sciences CrossRef
14. Effect of Oleic Acid on the Levels of Eight Metal Ions in Human Hepatoma SMMC-7721 Cells
    Song Wang et al, 2014, Biological Trace Element Research CrossRef
15. Aquaporin 9 Represents a Novel Target of Chronic Liver Injury That May Antagonize Its Progression by Reducing Lipotoxicity
    Quancheng Cheng et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
16. Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model
    Quancheng Cheng et al, 2022, International Journal of Biological Macromolecules CrossRef
17. Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism
    Manoj Limbraj Yellurkar et al, 2024, Journal of Ethnopharmacology CrossRef
18. Sex‐specific effect of AQP9 deficiency on hepatic triglyceride metabolism in mice with diet‐induced obesity
    Johanne Jul Elnegaard et al, 2024, The Journal of Physiology CrossRef
19. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress
    Caifeng Xie et al, 2016, Life Sciences CrossRef
20. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver
    Janne Lebeck, 2014, Journal of Molecular Endocrinology CrossRef
21. In situvisualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging
    Yongqing Zhou et al, 2020, Chemical Science CrossRef
22. Aquaporins in Biliary Function: Pathophysiological Implications and Therapeutic Targeting
    Mohamad Khalil et al, 2024, International Journal of Molecular Sciences CrossRef